STOCK TITAN
  1. Home
  2. Sec-filings
  3. KRMD
  4. [Form 4] KORU Medical Systems, Inc. Insider Trading Activity

KORU Medical Systems (KRMD) director awarded 3,571 common shares in Form 4 filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

French Donna reported acquisition or exercise transactions in this Form 4 filing.

KORU Medical Systems director Donna French received a grant of 3,571 shares of Common Stock at $4.20 per share. This was a compensation-related award, not an open-market purchase. Following the grant, she directly holds a total of 98,514 KORU Medical Systems shares.

Positive

  • None.

Negative

  • None.
Insider French Donna
Role null
Type Security Shares Price Value
Grant/Award Common Stock 3,571 $4.20 $15K
Holdings After Transaction: Common Stock — 98,514 shares (Direct, null)
Footnotes (1)
Shares granted 3,571 shares Grant of Common Stock to director Donna French
Grant price $4.20/share Reference price for Common Stock award
Total holdings after grant 98,514 shares Donna French direct ownership following transaction
Common Stock financial
"security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Grant, award, or other acquisition financial
"transaction_code_description: "Grant, award, or other acquisition""
Form 4 regulatory
"INSIDER FILING DATA (Form 4)"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
French Donna
(Last)(First)(Middle)
C/O KORU MEDICAL SYSTEMS, INC.
100 CORPORATE DRIVE
(Street)
MAHWAH NEW JERSEY 07430
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
KORU Medical Systems, Inc. [ KRMD ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/01/2026A3,571A$4.298,514D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
Remarks:
The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person. Power of Attorney has been previously filed.
/s/ Thomas Adams - Attorney-in-Fact07/01/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did KRMD director Donna French report on this Form 4?

Donna French reported receiving a grant of 3,571 KRMD common shares. The award was recorded at $4.20 per share and is categorized as a grant, award, or other acquisition rather than an open-market purchase or sale of stock.

Was Donna French’s KRMD transaction a stock purchase or a compensation grant?

The KRMD transaction was a compensation-related grant, not an open-market purchase. It is coded as a grant, award, or other acquisition, meaning the director received 3,571 shares as part of compensation rather than buying them in the market.

How many KRMD shares does Donna French hold after this reported transaction?

After receiving the 3,571-share grant, Donna French directly holds 98,514 KRMD common shares. This total reflects her ownership following the reported award and provides context for the size of the grant relative to her overall stake.

What was the reference price for the KRMD shares granted to Donna French?

The 3,571 KRMD shares granted to Donna French were recorded at $4.20 per share. This price is used for reporting the value of the compensation award and does not necessarily represent an open-market transaction price on that date.

Does this KRMD Form 4 show any stock sales or disposals by Donna French?

The KRMD Form 4 does not show any sales or disposals by Donna French. It reports only one transaction, a grant of 3,571 common shares, categorized as an acquisition related to compensation, with no indication of shares being sold or gifted.